US4057059A
(en)
*
|
1975-07-29 |
1977-11-08 |
Oklahoma State University |
Intermittent positive pressure breathing device
|
US4060078A
(en)
*
|
1975-08-18 |
1977-11-29 |
Bird F M |
Ventilator and method
|
US4003377A
(en)
*
|
1975-08-21 |
1977-01-18 |
Sandoz, Inc. |
Patient ventilator
|
US4098272A
(en)
*
|
1975-09-25 |
1978-07-04 |
Bio-Med Devices Inc. |
Respirator
|
US4141356A
(en)
*
|
1976-06-16 |
1979-02-27 |
Bourns, Inc. |
Respirator system and method
|
US4148312A
(en)
*
|
1976-10-08 |
1979-04-10 |
Minnesota Mining And Manufacturing Company |
Combination anesthesia and intensive care apparatus
|
US4155357A
(en)
*
|
1976-12-10 |
1979-05-22 |
Sandoz, Inc. |
Patient ventilator disconnect alarm
|
JPS5447900U
(xx)
*
|
1977-09-09 |
1979-04-03 |
|
|
US4197843A
(en)
*
|
1978-04-03 |
1980-04-15 |
Minnesota Mining And Manufacturing Company |
Volume limiting ventilator
|
WO1982003326A1
(en)
*
|
1981-03-26 |
1982-10-14 |
Kiszel Janos |
Respirator device particularly for use in perinatal medicine
|
DE3126207C2
(de)
*
|
1981-07-03 |
1983-11-17 |
Drägerwerk AG, 2400 Lübeck |
Zeitgesteuertes Beatmungsgerät
|
US4448192A
(en)
*
|
1982-03-05 |
1984-05-15 |
Hewlett Packard Company |
Medical ventilator device parametrically controlled for patient ventilation
|
US4459982A
(en)
*
|
1982-09-13 |
1984-07-17 |
Bear Medical Systems, Inc. |
Servo-controlled demand regulator for respiratory ventilator
|
US4702240A
(en)
*
|
1986-07-22 |
1987-10-27 |
Bear Medical Systems, Inc. |
Demand-responsive gas blending system for medical ventilator
|
US4931285A
(en)
*
|
1988-04-28 |
1990-06-05 |
Alza Corporation |
Aqueous based pharmaceutical coating composition for dosage forms
|
US5111809A
(en)
*
|
1988-12-01 |
1992-05-12 |
Avstar Aerospace Corporation |
Breathing system
|
DE3900276A1
(de)
*
|
1989-01-07 |
1990-07-12 |
Draegerwerk Ag |
Beatmungsgeraet mit atemkreislauf und gesteuerter frischgaszufuhr
|
US5086767A
(en)
*
|
1990-09-26 |
1992-02-11 |
Canadian Aging & Rehabilitation Product Development Corporation |
Ventilator for assisting the breathing of a patient
|
US5478577A
(en)
*
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
US7740881B1
(en)
|
1993-07-01 |
2010-06-22 |
Purdue Pharma Lp |
Method of treating humans with opioid formulations having extended controlled release
|
IL110014A
(en)
*
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
US5879705A
(en)
*
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
GB2282542B
(en)
*
|
1993-10-06 |
1997-06-25 |
Instruments & Movements Ltd |
Ventilators for promoting lung function
|
US5411745A
(en)
*
|
1994-05-25 |
1995-05-02 |
Euro-Celtique, S.A. |
Powder-layered morphine sulfate formulations
|
US6077533A
(en)
*
|
1994-05-25 |
2000-06-20 |
Purdue Pharma L.P. |
Powder-layered oral dosage forms
|
GB9422154D0
(en)
*
|
1994-11-03 |
1994-12-21 |
Euro Celtique Sa |
Pharmaceutical compositions and method of producing the same
|
FI974148A
(fi)
|
1997-11-05 |
1999-05-06 |
Instrumentarium Oy |
Menetelmä ja sovitelma hengityslaitteen yhteydessä
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
SI1685839T1
(sl)
|
1997-12-22 |
2013-08-30 |
Euro-Celtique S.A. |
Farmacevtska oralna dozirna oblika, ki vsebuje kombinacijo opioidnega agonista in opioidnega antagonista
|
AU1828599A
(en)
*
|
1997-12-29 |
1999-07-19 |
Alza Corporation |
Osmotic delivery system with membrane plug retention mechanism
|
AU1937099A
(en)
|
1997-12-31 |
1999-07-19 |
Alza Corporation |
Osmotic drug delivery monitoring system and method
|
TW407058B
(en)
|
1998-07-17 |
2000-10-01 |
Dev Center Biotechnology |
Oral cisapride dosage forms with an extended duration
|
US6806294B2
(en)
|
1998-10-15 |
2004-10-19 |
Euro-Celtique S.A. |
Opioid analgesic
|
ES2374717T3
(es)
|
1999-10-29 |
2012-02-21 |
Euro-Celtique S.A. |
Formulaciones de hidrocodona de liberación controlada.
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
NZ520554A
(en)
|
2000-02-08 |
2005-08-26 |
Euro Celtique S |
Tamper-resistant oral opioid agonist formulations
|
PL357158A1
(en)
|
2000-02-08 |
2004-07-12 |
Euro-Celtique, S.A. |
Controlled-release compositions containing opioid agonist and antagonist
|
JP2004512354A
(ja)
|
2000-10-30 |
2004-04-22 |
ユーロ−セルティーク,エス.エイ. |
ヒドロコドン放出制御製剤
|
CN1525851A
(zh)
|
2001-05-11 |
2004-09-01 |
������ҩ������˾ |
抗滥用阿片样物质控释剂型
|
DE60232417D1
(de)
|
2001-08-06 |
2009-07-02 |
Euro Celtique Sa |
Opioid-agonist-formulierungen mit freisetzbarem und sequestriertem antagonist
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
US20030157168A1
(en)
|
2001-08-06 |
2003-08-21 |
Christopher Breder |
Sequestered antagonist formulations
|
US7387123B2
(en)
*
|
2001-11-30 |
2008-06-17 |
Viasys Manufacturing, Inc. |
Gas identification system and volumetrically correct gas delivery system
|
KR20040098050A
(ko)
|
2002-04-05 |
2004-11-18 |
유로-셀띠끄 소시에떼 아노님 |
옥시코돈 및 날록손을 포함하는 약제학적 제제
|
EP1894562B1
(en)
|
2002-08-15 |
2010-12-15 |
Euro-Celtique S.A. |
Pharmaceutical compositions comprising an opioid antagonist
|
US7267120B2
(en)
|
2002-08-19 |
2007-09-11 |
Allegiance Corporation |
Small volume nebulizer
|
PT1551372T
(pt)
|
2002-09-20 |
2018-07-23 |
Alpharma Pharmaceuticals Llc |
Subunidade de sequestração e composições e métodos relacionados
|
CN101797221B
(zh)
|
2002-12-13 |
2013-06-12 |
杜雷科特公司 |
包含高粘度液体载体材料的口服递药系统
|
EP2339328A3
(en)
|
2002-12-30 |
2011-07-13 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of celecoxib
|
TWI347201B
(en)
|
2003-04-21 |
2011-08-21 |
Euro Celtique Sa |
Pharmaceutical products,uses thereof and methods for preparing the same
|
EP2298303A1
(en)
|
2003-09-25 |
2011-03-23 |
Euro-Celtique S.A. |
Pharmaceutical combinations of hydrocodone and naltrexone
|
DK1691811T3
(da)
|
2003-12-11 |
2014-10-20 |
Sunovion Pharmaceuticals Inc |
Kombination af et sedativ og en neurotransmittermodulator og fremgangsmåder til forbedring af søvnkvaliteten og behandling af depression
|
EP1604666A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
|
EP1604667A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the restless leg syndrome
|
ES2653568T3
(es)
|
2004-06-12 |
2018-02-07 |
Collegium Pharmaceutical, Inc. |
Formulaciones de fármacos para la prevención del abuso
|
WO2006007351A2
(en)
*
|
2004-06-28 |
2006-01-19 |
Alza Corporation |
Squeeze controlled oral dosage form
|
JP5704789B2
(ja)
*
|
2005-01-28 |
2015-04-22 |
ユーロ−セルティーク エス.エイ. |
耐アルコール性剤形
|
EP1702558A1
(en)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Method and device for the assessment of bowel function
|
EP1695700A1
(en)
*
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Dosage form containing oxycodone and naloxone
|
EP1813276A1
(en)
*
|
2006-01-27 |
2007-08-01 |
Euro-Celtique S.A. |
Tamper resistant dosage forms
|
US8158156B2
(en)
|
2006-06-19 |
2012-04-17 |
Alpharma Pharmaceuticals, Llc |
Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist
|
EP2019101A1
(en)
*
|
2007-07-26 |
2009-01-28 |
GPC Biotech AG |
Pyrazol[3,4-d]pyrimidin-4-one useful as Kinase Inhibitor
|
AU2008347158B8
(en)
|
2007-12-06 |
2013-08-22 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
AR074760A1
(es)
*
|
2008-12-18 |
2011-02-09 |
Metabolex Inc |
Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
|
EP2405915B1
(en)
|
2009-03-10 |
2018-10-24 |
Euro-Celtique S.A. |
Immediate release pharmaceutical compositions comprising oxycodone and naloxone
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
MY166034A
(en)
|
2010-12-22 |
2018-05-21 |
Purdue Pharma Lp |
Encased tamper resistant controlled release dosage forms
|
JP5638151B2
(ja)
|
2010-12-23 |
2014-12-10 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
不正加工抵抗性の(tamperresistant)固形経口剤形
|
WO2013049332A1
(en)
|
2011-09-29 |
2013-04-04 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
US9149533B2
(en)
|
2013-02-05 |
2015-10-06 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
WO2014144975A1
(en)
|
2013-03-15 |
2014-09-18 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
NZ716267A
(en)
|
2013-07-23 |
2017-05-26 |
Euro Celtique Sa |
A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
|
MX2016009300A
(es)
|
2014-01-15 |
2017-04-13 |
Rhodes Tech |
Proceso para la sintesis mejorada de oxicodona.
|
US10201667B2
(en)
|
2015-03-26 |
2019-02-12 |
Becton, Dickinson And Company |
IV membrane attachment systems and methods
|
US10232130B2
(en)
|
2015-03-26 |
2019-03-19 |
Becton, Dickinson And Company |
Anti-run dry membrane
|
US10702689B2
(en)
|
2015-03-26 |
2020-07-07 |
Becton, Dickinson And Company |
Auto-stop vent plug
|
US10646648B2
(en)
|
2015-04-01 |
2020-05-12 |
Becton, Dickinson And Company |
IV flow management systems and methods
|
WO2017222575A1
(en)
|
2016-06-23 |
2017-12-28 |
Collegium Pharmaceutical, Inc. |
Process of making more stable abuse-deterrent oral formulations
|
US10820833B2
(en)
|
2016-12-09 |
2020-11-03 |
Physio-Control, Inc. |
Capnograph system further detecting spontaneous patient breaths
|
WO2021188909A1
(en)
*
|
2020-03-19 |
2021-09-23 |
The Regents Of The University Of California |
Mechanical ventilator with a fixed number of orifice plates to generate constant flow paths
|